Trial registration number
|
ISRCTN18066414 |
Full text link
Last imported at : Aug. 5, 2021, 3:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
https://www.isrctn.com/ISRCTN18066414
|
First author
Last imported at : Aug. 5, 2021, 3:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Ana Maria Henao Restrepo
|
Contact
Last imported at : Aug. 5, 2021, 3:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
henaorestrepoa@who.int
|
Registration date
Last imported at : Aug. 5, 2021, 3:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
2021-07-29
|
Recruitment status
Last imported at : Aug. 5, 2021, 3:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Recruiting
|
Study design
Last imported at : Aug. 5, 2021, 3:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
RCT
|
Allocation
Last imported at : Aug. 5, 2021, 3:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Randomized
|
Design
Last imported at : Aug. 5, 2021, 3:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Parallel
|
Masking
Last imported at : Aug. 5, 2021, 3:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Open label
|
Center
Last imported at : Aug. 5, 2021, 3:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
multi-center
|
Study aim
Last imported at : Aug. 5, 2021, 3:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Treatment
|
Inclusion criteria
Last imported at : Aug. 5, 2021, 3:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
The only patients invited will be those admitted to a collaborating hospital, no wider recruitment is expected. 1. Adults (age =18 years, which allows consent) 2. Recently hospitalized (or already in hospital) with laboratory-confirmed COVID 3. Not expected to be transferred within 72 hours 4. With, in the view of their doctors, no contra-indication to any potentially relevant study drug
|
Exclusion criteria
Last imported at : Aug. 5, 2021, 3:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Does not meet inclusion criteria
|
Number of arms
Last imported at : Aug. 5, 2021, 3:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
3
|
Funding
Last imported at : Aug. 5, 2021, 3:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
World Health Organization
|
Inclusion age min
Last imported at : Aug. 5, 2021, 3:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
18
|
Inclusion age max
Last imported at : Aug. 5, 2021, 3:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
100
|
Countries
Last imported at : Aug. 5, 2021, 3:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Albania;Argentina;Bahamas;Bangladesh;Belize;Bolivia;Botswana;Brazil;India;Canada;Colombia;Dominican Republic;Ecuador;Egypt;Ethiopia;Finland;Guyana;Honduras;Indonesia;Ireland;Iran;Italy;Jamaica;Kenya;Kuwait;Latvia;Lebanon;Lithuania;Malaysia;Mali;Mexico;Mozambique;Niger;Nigeria;Norway;Oman;Pakistan;Panama;Paraguay;Peru;Philippines;Portugal;Romania;Saudi Arabia;Sierra Leone;United Kingdom;Spain;Switzerland;North Macedonia;Trinidad and Tobago;Zimbabwe
|
Type of patients
Last imported at : Aug. 5, 2021, 3:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Moderate/severe/critical disease at enrollment
|
Severity scale
Last imported at : Aug. 5, 2021, 3:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
5: Moderate/severe/critical disease at enrollment
|
Total sample size
Last imported at : Aug. 5, 2021, 3:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
10000
|
primary outcome
Last imported at : Aug. 5, 2021, 3:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
In-hospital mortality in all patients measured using patient records up to the end of hospital stay
|
Notes
Last imported at : Aug. 5, 2021, 3:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
| Declared number of arm (3.0)
differs from found arms (4.0)
|
Phase
Last imported at : Aug. 5, 2021, 3:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Not reported
|
Arms
Last imported at : Aug. 5, 2021, 3:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
[{"arm_notes": "", "treatment_id": 121, "treatment_name": "Artesunate", "treatment_type": "Antimalarials", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 650, "treatment_name": "Infliximab", "treatment_type": "Other targeted therapies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 631, "treatment_name": "Imatinib", "treatment_type": "Kinase inhibitors", "pharmacological_treatment": "Pharmacological treatment"}]
|